Table 1.
Univariate analysis | HR | 95% CI | P |
---|---|---|---|
Male | 1.903 | 1.029–3.522 | 0.040 |
Onset age >50 years | 3.339 | 1.786–6.243 | <0.001 |
Onset age <18 years | 1.001 | 0.535–1.872 | 0.998 |
Onset to diagnosis >1 year | 1.620 | 1.020–2.573 | 0.041 |
Baseline organ damage | 2.594 | 1.620–4.153 | <0.001 |
N | 2.323 | 1.444–3.738 | 0.001 |
HEMA | 1.310 | 0.825–2.081 | 0.252 |
ILD | 1.828 | 0.79504.206 | 0.156 |
NPLE | 2.539 | 1.267–5.087 | 0.009 |
PAH | 3.693 | 1.901–7.173 | <0.001 |
SERO | 2.090 | 1.276–3.422 | 0.003 |
Anti-dsDNA | 0.769 | 0.492–1.202 | 0.249 |
Anti-SM | 1.001 | 0.561–1.785 | 0.997 |
Anti-RNP | 1.512 | 0.817–2.798 | 0.188 |
Anti-SSA | 1.411 | 0.877–2.271 | 0.156 |
Anti-SSB | 1.302 | 0.688–2.464 | 0.417 |
Anti-rRNP | 0.951 | 0.429–2.108 | 0.901 |
APL | 1.150 | 0.581–2.277 | 0.688 |
Low completement | 0.958 | 0.603–1.522 | 0.856 |
Multivariate analysis | HR | 95% CI | P |
Male | 1.747 | 0.936–3.262 | 0.080 |
Onset age >50 years | 3.347 | 1.781–6.287 | <0.001 |
Onset to diagnosis >1 year | 1.604 | 1.006–2.558 | 0.047 |
LN | 2.055 | 1.264–3.341 | 0.004 |
NPLE | 2.550 | 1.252–5.196 | 0.010 |
PAH | 2.400 | 1.170–4.920 | 0.017 |
SERO | 1.575 | 0.938–2.646 | 0.086 |
Baseline organ damage | 1.907 | 1.169–3.110 | 0.010 |
HEMA, hematologic involvement; ILD, interstitial lung disease; LN, lupus nephritis; PAH, pulmonary arterial hypertension; SERO, serositis.